Warfarin therapy
190 results
1 - 100
Warfarin therapy - Essentials
- Indications for warfarin therapy
- Complications
- References
- Contraindications to warfarin therapy
- Initiation and intensity of warfarin therapy
- INR determinations
- Interactions
- Duration of the treatment
- Pregnancy and breastfeeding
- Temporary reduction of warfarin dose; bridging therapy
- Thrombosis despite warfarin therapy
- Warfarin therapy – Related resources
Don't add aspirin to warfarin therapy except with mechanical heart valve- Discontinuing warfarin therapy indefinitely after GI bleeding assoc with worse outcomes
- Warfarin or antiplatelet therapy for stroke prevention in patients with non-valvular atrial fibrillation
- Continued warfarin better than bridging therapy for pacemaker or defibrillator surgery (BRUISE CONTROL)
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias New- Benefits to resuming warfarin in patients with atrial fibrillation after intracranial bleeds
- Low-intensity warfarin for long-term prevention of venous thromboembolism
- Warfarin can safely be held for the short term
- 6 months of warfarin after aortic valve replacement reduces risk of CV death
- Warfarin superior to antiplatelet treatment for A Fib
- Antithrombotic agents in primary health care
- Indications for and implementation of anticoagulant therapy in atrial fibrillation
- Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter: Cochrane systematic review
- Many patients using warfarin also take aspirin
- Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
- Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE
- Warfarin initiation nomograms for venous thromboembolism: Cochrane systematic review
- Deep vein thrombosis – Related resources
- Warfarin: damned if you do, damned if you don't
- Percutaneous left atrial appendage closure reduces AF stroke risk
- More harm than good with bridge therapy in low-risk VTE patients
- Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks: Cochrane systematic review
- Anticoagulation for heart failure in sinus rhythm
- Optimal loading dose of warfarin for the initiation of oral anticoagulation: Cochrane systematic review
- Tinzaparin no better than warfarin in preventing recurrent VTE in adults with cancer
- Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease: Cochrane systematic review
- Genetic information does not add benefit to a clinical algorithm for warfarin management
- Dabigatran reduces risk of stroke and embolism in patients with AF
- Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm: Cochrane systematic review
- Bleeding risk with warfarin high among elderly, especially older than 80
- Clinically significant bleeding occurs in 3.8% per year of pts aged 65+ years using warfarin
- Prevention of venous thromboembolism
- Indications for and implementation of anticoagulant therapy in atrial fibrillation – Related resources
- Rivaroxaban + clopidogrel causes somewhat less bleeding than triple therapy in patients with AF undergoing PCI
- Deep vein thrombosis
- Dual therapy with dabigatran and clopidogrel preferred after PCI for patients with AF (RE-DUAL PCI)
- Extended anticoagulation may be helpul for patients with unprovoked VTE or PE
- Genotype-guided perioperative warfarin dosing may not be superior to algorithm-guided dosing
- Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks: Cochrane systematic review
- Rivaroxaban similar to warfarin for patients with NVAF
- Assessment and treatment of a patient with bleeding diathesis
- Vitamin K for improved anticoagulation control in patients receiving warfarin
- NOACs preferred over warfarin for nonvalvular atrial fibrillation in patients also taking low-dose aspirin
- Vitamin K for improved anticoagulation control in patients receiving warfarin: Cochrane systematic review
- Clopidogrel + ASA for afib: less strokes, more hemorrages (ACTIVE)
- Closure of PFO similar to medical therapy for cryptogenic stroke or TIA
- Joint injection okay in anticoagulated patients
- Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation: Cochrane systematic review
- Oral anticoagulant and antiplatelet therapy and peripheral arterial disease
- Treatment approach for atrial fibrillation: rate control or rhythm control?
- Anticoagulation reversal with vitamin K doesn't reduce bleeding
- Dabigatran cost-effective for AF prophylaxis in some patients, not others
- Rivaroxaban effective for acute DVT (EINSTEIN)
- Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack: Cochrane systematic review
- Coumadin + aspirin no better than aspirin alone for PAD
- Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks: Cochrane systematic review
- Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy: Cochrane systematic review
- Anticoagulation versus placebo for heart failure in sinus rhythm Edited (no change to conclusions)
- Transient ischaemic attack (TIA)
- Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack: Cochrane systematic review
- Systemic lupus erythematosus (SLE)
- Fungal infections of the mouth